Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-25 4:30 pm Purchase | 2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA | Theofilos Charles Steve | 2,506,321 5.900% | 2,506,321 (New Position) | Filing History |
| 2024-10-25 4:28 pm Purchase | 2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA | Patel Samir Rashmikant | 2,466,377 5.800% | 2,466,377 (New Position) | Filing History |
| 2024-10-25 4:26 pm Purchase | 2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA | KP Biotech Group LLC | 2,572,582 6.100% | 2,572,582 (New Position) | Filing History |
| 2024-10-25 4:23 pm Purchase | 2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA | CA Patel F&F Investments LLC | 2,572,582 6.100% | 2,572,582 (New Position) | Filing History |
| 2024-10-25 4:20 pm Purchase | 2024-10-18 | 13D | TuHURA Biosciences, Inc. HURA | Patel Vijay | 12,346,430 26.700% | 12,346,430 (New Position) | Filing History |
| 2024-10-25 4:16 pm Purchase | 2024-10-18 | 13D | TuHURA Biosciences, Inc. HURA | Bianco James A. | 2,704,901 6.400% | 2,704,901 (New Position) | Filing History |
| 2023-02-13 4:29 pm Purchase | 2022-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Lind Global Fund II LP | 2,156 0.100% | 2,156 (New Position) | Filing History |
| 2022-04-20 5:11 pm Purchase | 2022-04-14 | 13G | Kintara Therapeutics, Inc. KTRA | Lind Global Fund II LP | 2,156 5.800% | 2,156 (New Position) | Filing History |
| 2022-02-07 1:26 pm Sale | 2021-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Pilkiewicz Carolyn | 669 2.410% | -321 (-32.46%) | Filing History |
| 2021-02-08 3:18 pm Sale | 2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Pilkiewicz Carolyn | 990 7.030% | -300 (-23.25%) | Filing History |
| 2021-01-29 07:00 am Purchase | 2020-12-31 | 13G | Kintara Therapeutics, Inc. KTRA | Mitchell P. Kopin | 514 3.500% | 514 (New Position) | Filing History |
| 2020-11-16 2:37 pm Purchase | 2020-08-19 | 13G | Kintara Therapeutics, Inc. KTRA | Pilkiewicz Carolyn | 1,290 9.150% | 1,290 (New Position) | Filing History |
| 2020-08-28 4:05 pm Purchase | 2020-08-19 | 13G | Kintara Therapeutics, Inc. KTRA | STERN ADAM K | 945 6.950% | 945 (New Position) | Filing History |